US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Melatonin Receptor Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Melatonin Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Metabotropic Glutamate Receptor Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Metabotropic Glutamate Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Metal Ion Chelators -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Metal Ion Chelators Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Methionine Aminopeptidase 2 (Metap2) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Methionine Aminopeptidase 2 (Metap2) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
mGlu2 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The mGlu2 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, mGlu2 Agonists- ...  |  read more...
USD 1,250
mGlu3 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The mGlu3 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, mGlu3 Agonists- ...  |  read more...
USD 1,250
mGlu3 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The mGlu3 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, mGlu3 Antagonists- ...  |  read more...
USD 1,250
Microsomal Triglyceride Transfer Protein (MTP) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (MTP) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Microsomal Triglyceride Transfer Protein (MTP) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Mineralocorticoid Receptor (MR) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mineralocorticoid Receptor (MR) Antagonists Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Monoamine Oxidase B (MAO-B) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Monoamine Oxidase B (MAO-B) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Motilin Receptor Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Motilin Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Murine Double Minute 2 (MDM2) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (MDM2) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Murine Double Minute 2 (MDM2) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Muscarinic Acetylcholine Receptor M2 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Muscarinic Acetylcholine Receptor M2 Antagonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Muscarinic Acetylcholine Receptor M4 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Muscarinic Acetylcholine Receptor M4 Antagonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Muscarinic Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Muscarinic Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Muscarinic Agonists- ...  |  read more...
USD 1,250
Muscarinic M1 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Muscarinic M1 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Myosin Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Myosin Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Myosin Inhibitors- ...  |  read more...
USD 1,250
Myostatin Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Myostatin Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Myostatin Inhibitors- ...  |  read more...
USD 1,250
NADPH Oxidase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The NADPH Oxidase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Nerve Growth Factor (NGF) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Nerve Growth Factor (NGF) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Neurokinin 3 (NK3) Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neurokinin 3 (NK3) Receptor Antagonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Neurotrophic Factor Modulators -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neurotrophic Factor Modulators Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Nicotinic Acetylcholine Receptor (Nicotinic Receptor or nAChR) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Nicotinic Acetylcholine Receptor (Nicotinic Receptor or nAChR) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Nicotinic Acetylcholine Receptor (Nicotinic Receptor or ...  |  read more...
USD 1,250
Nicotinic Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Nicotinic Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Nicotinic Agonists- ...  |  read more...
USD 1,250
NMDA Receptor 2B Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The NMDA Receptor 2B Antagonists Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
6  7  8  9    11    13  14  15